During the past decade, Summa Center for Cancer Care at Akron City Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 101 clinical trials were completed, i.e. on average, 3366.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 29 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Summa Center for Cancer Care at Akron City Hospital" #1 sponsor was "Radiation Therapy Oncology Group" with 40 trials, followed by "National Cancer Institute (NCI)" with 29 trials sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "Eastern Cooperative Oncology Group" with 14 trials sponsored and "Gynecologic Oncology Group" with 14 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Summa Center for Cancer Care at Akron City Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 106 trials as a collaborator, "NRG Oncology" with 44 trials as a collaborator, "Radiation Therapy Oncology Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Summa Center for Cancer Care at Akron City Hospital" are "Prostate Cancer" (15 trials), "Breast Cancer" (14 trials), "Lung Cancer" (12 trials), "Recurrent Ovarian Carcinoma" (7 trials) and "Lymphoma" (6 trials). Many other conditions were trialed in "Summa Center for Cancer Care at Akron City Hospital" in a lesser frequency.

Most popular intervention types in "Summa Center for Cancer Care at Akron City Hospital" are "Drug" (105 trials), "Radiation" (58 trials), "Other" (48 trials), "Biological" (37 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (24 trials), "Paclitaxel" (13 trials), "Placebo" (12 trials), "Bevacizumab" (11 trials) and "Quality-of-Life Assessment" (11 trials). Other intervention names were less common.

The vast majority of trials in "Summa Center for Cancer Care at Akron City Hospital" are 89 trials for "All" genders, 37 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "Summa Center for Cancer Care at Akron City Hospital". undefined are not yet recruiting, undefined are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 94 completed trials in Summa Center for Cancer Care at Akron City Hospital, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Summa Center for Cancer Care at Akron City Hospital, 7 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".